Frontiers in Oncology
Latinos and Cancer: Creating a Better Survivorship Journey
June 7, 2022
Amelie G. Ramirez, DrPH, an internationally recognized cancer and chronic disease health disparities and health promotion researcher, is chair and professor of Population Health Sciences at UT Health San Antonio, where she also is founding director of the Institute for Health Promotion Research, and associate director of cancer outreach and engagement at the Mays Cancer Center at UT Health San Antonio. Dr. Ramirez has directed over 100 research programs focused on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos and other minority and underserved populations, including cancer risk factors, clinical trial recruitment, patient navigation, tobacco prevention, obesity prevention, and more. She has authored many peer-reviewed articles, is an editorial board member on several prestigious journals, and is frequently invited to speak at scientific meetings. She has been widely recognized for her work to improve Latino health and advance Latinos in medicine, public health, and behavioral sciences across the U.S. Dr. Ramirez is on the San Antonio Mayor’s Fitness Council and is Board President of The Academy of Medicine, Engineering and Science of Texas. Dr. Ramirez is a native of Laredo, Texas. She received her MPH and DrPH degrees from The University of Texas Health Science Center at Houston.
Frontiers in Oncology
Frontiers in Oncology, a recurring seminar series organized by the Stanford Cancer Institute, is designed to highlight innovations in cancer research across the spectrum of basic, translational, clinical and population science. The dynamic speakers represent a broad range of disciplines and expertise from both Stanford faculty and national thought leaders. The audience for this seminar series includes Stanford faculty, trainees and staff as well as anyone in the broader community with an interest in cancer research. Each recorded seminar is approximately 1 hour in length.
You may also be interested in the Frontiers in Cancer Clinical Translation Seminar Series sponsored by the Division of Oncology.